Exploring the potential of gut microbiota metabolites in the treatment of endometriosis through network pharmacology and Mendelian randomization
dataset
OA: green
CC0
AI-generated summary
This study utilized network pharmacology and Mendelian randomization to identify gut microbial metabolites and their associated genes as potential therapeutic targets for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study investigated the potential role of gut microbiota metabolites in endometriosis using network pharmacology and Mendelian randomization. Key biomarker genes related to protective gut microbial metabolites were identified and analyzed. The research provides new insights and potential therapeutic targets for understanding the pathogenesis and intervention of endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK